Skip to content
healthcare.dev

RANOLAZINE

NDC 71335-2556, RANOLAZINE, tablet, film coated, extended release, from Bryant Ranch Prepack.

Product NDC
71335-2556
Status
Listed
Labeler
Bryant Ranch Prepack
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213517
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71335-2556 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE500 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
71335-2556-17133525560160 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71335-2556-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9199e28a-ddbe-46a4-ab26-9b08034289be

Use it

Look up 71335-2556 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71335-2556 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71335-2556. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.